Follow
Jonathan P  Schneck
Jonathan P Schneck
Professor of Pathology, Johns Hopkins School of Medicine
Verified email at jhmi.edu - Homepage
Title
Cited by
Cited by
Year
Tumor and microenvironment evolution during immunotherapy with nivolumab
N Riaz, JJ Havel, V Makarov, A Desrichard, WJ Urba, JS Sims, FS Hodi, ...
Cell 171 (4), 934-949. e16, 2017
13102017
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
S Nagaraj, K Gupta, V Pisarev, L Kinarsky, S Sherman, L Kang, ...
Nature medicine 13 (7), 828-835, 2007
12292007
Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig–coated artificial antigen-presenting cells
M Oelke, MV Maus, D Didiano, CH June, A Mackensen, JP Schneck
Nature medicine 9 (5), 619-625, 2003
3812003
Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex
JE Slansky, FM Rattis, LF Boyd, T Fahmy, EM Jaffee, JP Schneck, ...
Immunity 13 (4), 529-538, 2000
3632000
Attrition of T cell memory: selective loss of LCMV epitope–specific memory CD8 T cells following infections with heterologous viruses
LK Selin, MY Lin, KA Kraemer, DM Pardoll, JP Schneck, SM Varga, ...
Immunity 11 (6), 733-742, 1999
3141999
T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens
MA Brehm, AK Pinto, KA Daniels, JP Schneck, RM Welsh, LK Selin
Nature immunology 3 (7), 627-634, 2002
2872002
Direct visualization of antigen-specific T cells: HTLV-1 Tax11–19- specific CD8+ T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from …
TF Greten, JE Slansky, R Kubota, SS Soldan, EM Jaffee, TP Leist, ...
Proceedings of the National Academy of Sciences 95 (13), 7568-7573, 1998
2861998
Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen
TM Fahmy, JG Bieler, M Edidin, JP Schneck
Immunity 14 (2), 135-143, 2001
2772001
Adoptive T cell immunotherapy for cancer
K Perica, JC Varela, M Oelke, J Schneck
Rambam Maimonides medical journal 6 (1), 2015
2352015
A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations.
J Dal Porto, TE Johansen, B Catipović, DJ Parfiit, D Tuveson, U Gether, ...
Proceedings of the National Academy of Sciences 90 (14), 6671-6675, 1993
2171993
Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells
JC Sunshine, K Perica, JP Schneck, JJ Green
Biomaterials 35 (1), 269-277, 2014
2072014
Lectin microarrays identify cell-specific and functionally significant cell surface glycan markers
SC Tao, Y Li, J Zhou, J Qian, RL Schnaar, Y Zhang, IJ Goldstein, H Zhu, ...
Glycobiology 18 (10), 761-769, 2008
1952008
Magnetic field-induced T cell receptor clustering by nanoparticles enhances T cell activation and stimulates antitumor activity
K Perica, A Tu, A Richter, JG Bieler, M Edidin, JP Schneck
ACS nano 8 (3), 2252-2260, 2014
1922014
Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T CellsTCR Repertoire Shaped by Radiation and CTLA-4 Blockade
NP Rudqvist, KA Pilones, C Lhuillier, E Wennerberg, JW Sidhom, ...
Cancer immunology research 6 (2), 139-150, 2018
1632018
Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy
K Bieganowska, P Höllsberg, GJ Buckle, DG Lim, TF Greten, J Schneck, ...
The Journal of Immunology 162 (3), 1765-1771, 1999
1591999
Lateral diffusion of GFP-tagged H2Ld molecules and of GFP-TAP1 reports on the assembly and retention of these molecules in the endoplasmic reticulum
D Marguet, ET Spiliotis, T Pentcheva, M Lebowitz, J Schneck, M Edidin
Immunity 11 (2), 231-240, 1999
1481999
Biodegradable nanoellipsoidal artificial antigen presenting cells for antigen specific T‐cell activation
RA Meyer, JC Sunshine, K Perica, AK Kosmides, K Aje, JP Schneck, ...
Small 11 (13), 1519-1525, 2015
1472015
Major histocompatibility complex conformational epitopes are peptide specific.
B Catipović, J Dal Porto, M Mage, TE Johansen, JP Schneck
The Journal of experimental medicine 176 (6), 1611-1618, 1992
1461992
Increased Activated Human T Cell Lymphotropic Virus Type I (HTLV-I) Tax11-19-Specific Memory and Effector CD8+ Cells in Patients with HTLV-I-Associated …
M Nagai, R Kubota, TF Greten, JP Schneck, TP Leist, S Jacobson
The Journal of infectious diseases 183 (2), 197-205, 2001
1392001
Inhibition of an allospecific T cell hybridoma by soluble class I proteins and peptides: estimation of the affinity of a T cell receptor for MHC
J Schneck, WL Maloy, JE Coligan, DH Margulies
Cell 56 (1), 47-55, 1989
1361989
The system can't perform the operation now. Try again later.
Articles 1–20